{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:58:11Z","timestamp":1770501491552,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1038\/4743","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:58Z","timestamp":1027672498000},"page":"56-63","source":"Crossref","is-referenced-by-count":447,"title":["Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector"],"prefix":"10.1038","volume":"5","author":[{"given":"Roland W.","family":"Herzog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda B.","family":"Couto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Nathan","family":"Hagstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Elwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight A.","family":"Bellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie S.","family":"Read","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth M.","family":"Brinkhous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Podsakoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary J.","family":"Kurtzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"High","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnm0199_56_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2796.1997.130135000.x","volume":"241","author":"T Lofqvist","year":"1997","unstructured":"Lofqvist, T., Nilsson, I.M., Berntorp, E. & Pettersson, H. Haemophilia prophylaxis in young patients\u2014a long term follow up. J. Int. Med. 241, 395\u2013400 (1997).","journal-title":"J. Int. Med."},{"key":"BFnm0199_56_CR2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V51.6.1179.1179","volume":"51","author":"ME Eyster","year":"1978","unstructured":"Eyster, M.E. et al. Central nervous system bleeding in hemophiliacs. Blood 51, 1179\u20131188 ( 1978).","journal-title":"Blood"},{"key":"BFnm0199_56_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/archpedi.1987.04460110085030","volume":"141","author":"GL Bray","year":"1987","unstructured":"Bray, G.L. & Lubahn, N.L. Hemophilia presenting with\u2013intracranial hemorrhage. An approach to the infant with intracranial bleeding and coagulopathy. Am. J. Dis. Children 141, 1215\u2013 1217 (1987).","journal-title":"Am. J. Dis. Children"},{"key":"BFnm0199_56_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1055\/s-0038-1657619","volume":"78","author":"JM Lusher","year":"1997","unstructured":"Lusher, J.M. Prophylaxis in children with hemophilia: Is it the optimal treatment? Thromb. Haemost. 78, 726\u2013729 (1997).","journal-title":"Thromb. Haemost."},{"key":"BFnm0199_56_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1046\/j.1365-2516.1997.00100.x","volume":"3","author":"MV Ragni","year":"1997","unstructured":"Ragni, M.V., Hord, J.D. & Blatt, J. Central venous catheter infection in hemophiliacs undergoing prophylaxis or immune tolerance with clotting factor concentrate. Haemophilia 3, 90\u201395 ( 1997).","journal-title":"Haemophilia"},{"key":"BFnm0199_56_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.8211118","volume":"262","author":"MA Kay","year":"1993","unstructured":"Kay, M.A. et al. In vivo gene therapy of hemophilia B: Sustained partial correction in factor IX-deficient dogs. Science 262 , 117\u2013119 (1993).","journal-title":"Science"},{"key":"BFnm0199_56_CR7","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1073\/pnas.94.11.5804","volume":"94","author":"RW Herzog","year":"1997","unstructured":"Herzog, R.W. et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Nat. Acad. Sci. USA 94, 5804\u2013 5809 (1997).","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"BFnm0199_56_CR8","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/JVI.70.11.8098-8108.1996","volume":"70","author":"X Xiao","year":"1996","unstructured":"Xiao, X., Li, J. & Samulski, R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098\u20138108 ( 1996).","journal-title":"J. Virol."},{"key":"BFnm0199_56_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/sj.gt.3300548","volume":"5","author":"PE Monahan","year":"1998","unstructured":"Monahan P.E. et al. Direct intramuscular injection with recombinant\u2013AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. 5, 40\u201349 ( 1998).","journal-title":"Gene Ther."},{"key":"BFnm0199_56_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm0397-306","volume":"3","author":"KJ Fisher","year":"1997","unstructured":"Fisher, K.J. et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med. 3:306\u2013 312 (1997).","journal-title":"Nature Med."},{"key":"BFnm0199_56_CR11","first-page":"99","volume":"1","author":"S-N Yao","year":"1994","unstructured":"Yao, S.-N., Smith, K.J. & Kurachi, K. Primary myoblast-mediated gene transfer: Persistent expression of human factor IX in mice. Gene Ther. 1 , 99\u2013107 (1994).","journal-title":"Gene Ther."},{"key":"BFnm0199_56_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/38410","volume":"389","author":"IM Verma","year":"1997","unstructured":"Verma, I.M. & Somia, N. Gene therapy - promises, problems and prospects. Nature 389, 239\u2013 242 (1997).","journal-title":"Nature"},{"key":"BFnm0199_56_CR13","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1073\/pnas.91.6.2353","volume":"91","author":"MA Kay","year":"1994","unstructured":"Kay, M.A. et al. In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. USA 91, 2353\u20132357 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0199_56_CR14","first-page":"217","volume":"3","author":"B Fang","year":"1996","unstructured":"Fang, B. et al. Lack of persistence of E1\u2013 recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther. 3, 217\u2013222 (1996).","journal-title":"Gene Ther."},{"key":"BFnm0199_56_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm0798-775","volume":"4","author":"DB Kohn","year":"1998","unstructured":"Kohn, D.B. et al. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nature Med. 4, 775\u2013780 (1998).","journal-title":"Nature Med."},{"key":"BFnm0199_56_CR16","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1002\/1097-0142(19910515)67:10+<2700::AID-CNCR2820671705>3.0.CO;2-3","volume":"67","author":"AW Nienhuis","year":"1991","unstructured":"Nienhuis, A.W., McDonagh, K.T. & Bodine, D.M. Gene transfer into hematopoietic stem cells. Cancer 67, 2700\u20132704 ( 1991).","journal-title":"Cancer"},{"key":"BFnm0199_56_CR17","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/sj.gt.3300680","volume":"5","author":"T Matsushita","year":"1998","unstructured":"Matsushita, T. et al. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 5, 938\u2013 945 (1998).","journal-title":"Gene Ther."},{"key":"BFnm0199_56_CR18","doi-asserted-by":"publisher","first-page":"10095","DOI":"10.1073\/pnas.86.24.10095","volume":"86","author":"JP Evans","year":"1989","unstructured":"Evans, J.P., Brinkhous, K.M., Brayer, G.D., Reisner. H.W. & High, K.A. Canine hemophilia B resulting from a point mutation with unusual consequences. Proc. Natl. Acad. Sci. USA 86, 10095\u201310099 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0199_56_CR19","first-page":"216","volume-title":"Animals for Medical Research\u2013Models for the Study of Human Disease","author":"BM Mitruka","year":"1976","unstructured":"Mitruka, B.M., Rawnsley, H.M. & Vadehra, D.V. in Animals for Medical Research\u2013Models for the Study of Human Disease. 216 (John Wiley & Sons, New York, 1976)."},{"key":"BFnm0199_56_CR20","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1182\/blood.V91.12.4600","volume":"91","author":"H Nakai","year":"1998","unstructured":"Nakai, H. et al. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91, 4600\u20134607 (1998).","journal-title":"Blood"},{"key":"BFnm0199_56_CR21","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1128\/JVI.70.5.3207-3214.1996","volume":"70","author":"JF Baskar","year":"1996","unstructured":"Baskar, J.F. et al. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70, 3207 (1996).","journal-title":"J. Virol."},{"key":"BFnm0199_56_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1073\/pnas.89.1.89","volume":"89","author":"MA Kay","year":"1991","unstructured":"Kay, M.A. et al. Expression of human alpha1-antitrypsin in dogs after autologous trannsplantation of retroviral transduced hepatocytes. Proc. Natl. Acad. Sci. USA 89, 89\u201393 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0199_56_CR23","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1089\/hum.1997.8.15-1797","volume":"8","author":"EC Svensson","year":"1997","unstructured":"Svensson, E.C. et al. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum. Gene Ther. 8, 1797\u2013 1806 (1997).","journal-title":"Hum. Gene Ther."},{"key":"BFnm0199_56_CR24","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/hmg\/5.11.1703","volume":"5","author":"Y Yang","year":"1996","unstructured":"Yang, Y., Haecker, S.E., Su, Q. & Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Molec. Genet. 5, 1703\u20131712 (1996).","journal-title":"Hum. Molec. Genet."},{"key":"BFnm0199_56_CR25","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1073\/pnas.92.5.1401","volume":"92","author":"Y Dai","year":"1995","unstructured":"Dai. Y. et al. Cellular and humoral responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401\u20131405 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0199_56_CR26","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.72.5.4212-4223.1998","volume":"72","author":"K Jooss","year":"1998","unstructured":"Jooss, K., Yang, Y., Fisher, K.J. & Wilson, J.M. Transduction of dentritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72, 4212\u20134223 (1998).","journal-title":"J. Virol."},{"key":"BFnm0199_56_CR27","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","volume":"72","author":"X Xiao","year":"1998","unstructured":"Xiao, X., Li, J. & Samulski, R.J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224\u20132232 (1998).","journal-title":"J. Virol."},{"key":"BFnm0199_56_CR28","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nm1197-1295","volume":"3","author":"FK Ferrari","year":"1997","unstructured":"Ferrari, F.K., Xiao, X., McCarty, D. & Samulski, R.J. New developments in the generation of Ad-free, high titer rAAV gene therapy vectors. Nature Med. 3, 1295\u20131297 (1997).","journal-title":"Nature Med."},{"key":"BFnm0199_56_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-4613-0331-2_6","volume":"386","author":"KA High","year":"1995","unstructured":"High, K.A. Factor IX: Molecular structure, epitopes, and mutations associated with inhibitor formation. Adv. Exp. Med. Biol. 386, 79\u2013 86 (1995).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnm0199_56_CR30","first-page":"2428","volume":"83","author":"GL Bray","year":"1994","unstructured":"Bray, G.L. et al. A Multicenter study of recombinant factor VIII (Recombinate): Safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. Blood 83, 2428\u2013 2435 (1994).","journal-title":"Blood"},{"key":"BFnm0199_56_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJM199302183280701","volume":"328","author":"JM Lusher","year":"1993","unstructured":"Lusher, J.M., Arkin, S., Abildgaard, C.F. & Schwartz. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. N. Engl. J. Med. 328, 453\u2013459 ( 1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0199_56_CR32","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood.V82.8.2452.2452","volume":"82","author":"JGG Gilles","year":"1993","unstructured":"Gilles, J.G.G., Arnout, J., Vermylen, J. & Saint-Remy, J.-M.R. Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction. Blood 82, 2452\u20132461 (1993).","journal-title":"Blood"},{"key":"BFnm0199_56_CR33","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1172\/JCI118558","volume":"97","author":"JG Gilles","year":"1996","unstructured":"Gilles, J.G., Desqueper, B., Lenk, H., Vermylen, J. & Saint-Remy, J.M. Neutralizing anti-idiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. J. Clin. Invest. 97: 1382\u20131388 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnm0199_56_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng0598-13","volume":"19","author":"CH Miao","year":"1998","unstructured":"Miao, C.H. et al. The kinetics of rAAV integration in the liver. Nat. Genet. 19, 13\u201315 ( 1998).","journal-title":"Nat. Genet."},{"key":"BFnm0199_56_CR35","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1128\/JVI.72.11.8568-8577.1998","volume":"72","author":"D Duan","year":"1998","unstructured":"Duan, D. et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72, 8568\u20138577 (1998).","journal-title":"J. Virol."},{"key":"BFnm0199_56_CR36","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1128\/JVI.70.5.3235-3241.1996","volume":"70","author":"SA Afione","year":"1996","unstructured":"Afione, S.A. et al. In vivo model of adeno-associated virus vector persistence and rescue. J Virol 70, 3235\u2013 3241 (1996).","journal-title":"J Virol"},{"key":"BFnm0199_56_CR37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood.V74.1.207.207","volume":"74","author":"JP Evans","year":"1989","unstructured":"Evans, J.P., Watzke, H.H., Ware, J.L., Stafford, D.W. & High, K.A. Molecular cloning of a cDNA encoding canine factor IX. Blood 74, 207\u2013212 (1989).","journal-title":"Blood"},{"key":"BFnm0199_56_CR38","doi-asserted-by":"publisher","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","volume":"93","author":"PD Kessler","year":"1996","unstructured":"Kessler, P.D. et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082\u201314087 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0199_56_CR39","first-page":"592a","volume":"82","author":"KM Brinkhous","year":"1993","unstructured":"Brinkhous K.M., Landen, C.N. & Read, M.S. Evaluation of sensitivity of whole blood clotting time (WBCT), partial thromboplastin time (PTT), and F.IX one-stage bioassay tests with low plasma F.IX levels observed with transfusion or gene therapy in canine hemophilia B. Blood 82, Suppl.1, 592a (1993).","journal-title":"Blood"},{"key":"BFnm0199_56_CR40","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1073\/pnas.93.7.3056","volume":"93","author":"J Walter","year":"1996","unstructured":"Walter, J., You, Q., Hagstrom, N., Sands, M. & High, K.A. Successful expression of human factor IX following repeat administration of an adenoviral vector in mice. Proc. Natl. Acad. Sci. USA 93, 3056\u20133061 ( 1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0199_56_CR41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood.V91.3.784","volume":"91","author":"S-H Kung","year":"1998","unstructured":"Kung, S.-H. et al. Human factor IX corrects the bleeding diathesis of mice with hemophilia B. Blood 91, 784\u2013 790 (1998).","journal-title":"Blood"},{"key":"BFnm0199_56_CR42","first-page":"9.16","volume-title":"Molecular Cloning","author":"J Sambrook","year":"1989","unstructured":"Sambrook, J., Fritsch, E.F. & Maniatis, T. in Molecular Cloning (ed. Nolan, C.) 9.16 \u20139.19 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York,1989)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0199_56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0199_56","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0199_56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:31:11Z","timestamp":1684452671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0199_56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["BFnm0199_56"],"URL":"https:\/\/doi.org\/10.1038\/4743","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}